ALIBX
Price
$13.22
Change
+$0.03 (+0.23%)
Updated
Oct 17 closing price
Net Assets
12.75M
RLBBX
Price
$38.66
Change
+$0.03 (+0.08%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

ALIBX vs RLBBX

Header iconALIBX vs RLBBX Comparison
Open Charts ALIBX vs RLBBXBanner chart's image
ALPS/Smith Balanced Opportunity I
Price$13.22
Change+$0.03 (+0.23%)
VolumeN/A
Net Assets12.75M
American Funds American Balanced R2
Price$38.66
Change+$0.03 (+0.08%)
VolumeN/A
Net Assets265.37B
ALIBX vs RLBBX Comparison Chart in %
View a ticker or compare two or three
VS
ALIBX vs. RLBBX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALIBX is a Hold and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 265B vs. ALIBX (12.8M). ALIBX pays higher dividends than RLBBX: ALIBX (1.62) vs RLBBX (1.11). ALIBX was incepted earlier than RLBBX: ALIBX (5 years) vs RLBBX (23 years). ALIBX (2.64) is less costly to investors than RLBBX (1.32). ALIBX is a more actively managed with annual turnover of: 131.00 vs. RLBBX (44.00). RLBBX has a lower initial minimum investment than ALIBX: RLBBX (250) vs ALIBX (2500). RLBBX annual gain was more profitable for investors over the last year : 7.84 vs. ALIBX (-0.46). ALIBX (38.32) and RLBBX (37.69) have equivalent 5 years return.
ALIBXRLBBXALIBX / RLBBX
Total Expense Ratio1.151.3287%
Annual Report Gross Expense Ratio2.641.32200%
Fund Existence5 years23 years-
Gain YTD9.70813.93870%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.8M265B0%
Annual Yield % from dividends1.621.11147%
Returns for 1 year-0.467.84-6%
Returns for 3 years38.6447.4381%
Returns for 5 years38.3237.69102%
Returns for 10 yearsN/A67.64-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACIW48.750.57
+1.18%
ACI Worldwide
FRST9.650.06
+0.63%
Primis Financial Corp
INVA17.270.02
+0.12%
Innoviva
CLGN2.32-0.02
-0.64%
CollPlant Biotechnologies Ltd
BCS19.36-0.59
-2.96%
Barclays PLC